Adaptation of Impression Cytology to Enable Conjunctival Surface Cell Transcriptome Analysis

Abstract Purpose: This study investigates the extent of the human transcriptome that can be quantified from conjunctival impression cytology extracts. The aim is to determine if sufficient RNA can be isolated from a patient’s conjunctival surface to identify differences in gene expression between dry eye and normal patients of (a) an array of 96 inflammatory biomarkers and associated receptors, and (b) if this comparison can be expanded to the entire transcriptome. Materials and Methods: CIC was used to collect conjunctival surface cells from 53 qualifying normal and dry eye patients. Based on prior optimization of all assay steps, RNA was isolated from the samples using a Qiagen RNeasy Plus Mini Kit and qRT-PCR was used to determine gene expression of 96 genes using TaqMan Low Density Array cards. Samples from six normal and six dry eye patients were then assayed on an Illumina Human HT-12 BeadChip. Results: Optimization steps yielded an RNA processing procedure that improved yield from an initial 12 genes through 96, then to the entire human transcriptome. For the HT-12 BeadChip, more than 30 genes differed by a factor of >1.5 between the dry eye and normal groups and seven genes were down-regulated by a factor of >2.0 in the dry eye group: HLA-DRB5, PSCA, FOS, lysozyme, TSC22D1, CAPN13 and CXCL6. Conclusions: Conjunctival impression cytology can be used to collect sufficient RNA from conjunctival surface cells that, when processed optimally, allows successful transcriptome-wide expression analysis. While the current transcriptome analysis used a limited patient group, larger studies of patients with various types and severities of dry eye should reveal significant gene expression trends that can then be targeted to improve dry eye treatment options.

[1]  Gerd Geerling,et al.  Correlations between commonly used objective signs and symptoms for the diagnosis of dry eye disease: clinical implications , 2014, Acta ophthalmologica.

[2]  M. Beasley,et al.  Comparison of low-abundance biomarker levels in capillary-collected nonstimulated tears and washout tears of aqueous-deficient and normal patients. , 2013, Investigative ophthalmology & visual science.

[3]  F. Takeuchi,et al.  The genetic contribution of HLA‐DRB5*01:01 to systemic lupus erythematosus in Thailand , 2013, International journal of immunogenetics.

[4]  H. Yamanaka,et al.  Up-regulated expression of HLA-DRB5 transcripts and high frequency of the HLA-DRB5*01:05 allele in scleroderma patients with interstitial lung disease. , 2012, Rheumatology.

[5]  L. Módis,et al.  Evaluation of Tear Osmolarity in Non-Sjögren and Sjögren Syndrome Dry Eye Patients With the TearLab System , 2012, Cornea.

[6]  S. Bowman,et al.  Biologic therapies in primary Sjögren's syndrome. , 2012, Current pharmaceutical biotechnology.

[7]  Toshiharu Hayashi Dysfunction of Lacrimal and Salivary Glands in Sjögren's Syndrome: Nonimmunologic Injury in Preinflammatory Phase and Mouse Model , 2011, Journal of biomedicine & biotechnology.

[8]  Gerd Geerling,et al.  An objective approach to dry eye disease severity. , 2010, Investigative ophthalmology & visual science.

[9]  J. Daniels,et al.  Clinical Trials of Therapeutic Ocular Surface Medium for Moderate to Severe Dry Eye , 2010, Cornea.

[10]  E. Campos,et al.  Tear proteomics in evaporative dry eye disease , 2010, Eye.

[11]  M. Burton,et al.  Conjunctival expression of matrix metalloproteinase and proinflammatory cytokine genes after trichiasis surgery. , 2010, Investigative ophthalmology & visual science.

[12]  J. Gu,et al.  Prostate Stem Cell Antigen: A Jekyll and Hyde Molecule? , 2010, Clinical Cancer Research.

[13]  B. Bucheton,et al.  IL-17 and IL-22 are associated with protection against human kala azar caused by Leishmania donovani. , 2009, The Journal of clinical investigation.

[14]  Johnny L Gayton,et al.  etiology , prevalence , and treatment of dry eye disease , 2009 .

[15]  M. Senchyna,et al.  Tear Lipocalin and Lysozyme in Sjögren and Non-Sjogren Dry Eye , 2008, Optometry and vision science : official publication of the American Academy of Optometry.

[16]  L. Donnelly,et al.  Th17 cells in airway diseases. , 2008, Current molecular medicine.

[17]  M. Malmsten,et al.  The Human CXC Chemokine Granulocyte Chemotactic Protein 2 (GCP-2)/CXCL6 Possesses Membrane-Disrupting Properties and Is Antibacterial , 2008, Antimicrobial Agents and Chemotherapy.

[18]  Stefano Barabino,et al.  Topical omega-3 and omega-6 fatty acids for treatment of dry eye. , 2008, Archives of ophthalmology.

[19]  R. Fullard,et al.  Multiple Cytokine Analysis in Human Tears: An Optimized Procedure for Cytometric Bead-Based Assay , 2008, Current eye research.

[20]  D. Korb,et al.  An Evaluation of the Efficacy of Fluorescein, Rose Bengal, Lissamine Green, and a New Dye Mixture for Ocular Surface Staining , 2008, Eye & contact lens.

[21]  Christophe Baudouin,et al.  The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007). , 2007, The ocular surface.

[22]  N. Ishimaru,et al.  Analysis of in Vivo Role of α-Fodrin Autoantigen in Primary Sjögren’s Syndrome , 2005 .

[23]  R. Hipskind,et al.  Down-Regulation of c-Fos/c-Jun AP-1 Dimer Activity by Sumoylation , 2005, Molecular and Cellular Biology.

[24]  H. Friess,et al.  Prostate Stem Cell Antigen Is a Putative Target for Immunotherapy in Pancreatic Cancer , 2005, Pancreas.

[25]  M. Zatz,et al.  Calpains and disease. , 2005, The New England journal of medicine.

[26]  T. Fujimori,et al.  TSC-22 (TGF-beta stimulated clone-22): a novel molecular target for differentiation-inducing therapy in salivary gland cancer. , 2004, Current cancer drug targets.

[27]  Zhao Zhigang,et al.  Prostate stem cell antigen (PSCA) expression in human prostate cancer tissues: implications for prostate carcinogenesis and progression of prostate cancer. , 2004, Japanese journal of clinical oncology.

[28]  K. Okubo,et al.  Up-regulated gene expression in the conjunctival epithelium of patients with Sjögren's syndrome. , 2003, Experimental eye research.

[29]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[30]  R. Jonsson,et al.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group , 2002, Annals of the rheumatic diseases.

[31]  B. Nakken,et al.  Associations of MHC Class II Alleles in Norwegian Primary Sjögren's Syndrome Patients: Implications for Development of Autoantibodies to the Ro52 Autoantigen , 2001, Scandinavian journal of immunology.

[32]  S. Pflugfelder,et al.  Altered cytokine balance in the tear fluid and conjunctiva of patients with Sjögren's syndrome keratoconjunctivitis sicca. , 1999, Current eye research.

[33]  G. Foulks,et al.  Evaluation of the effect of lissamine green and rose bengal on human corneal epithelial cells. , 1999, Cornea.

[34]  P Cho,et al.  Schirmer test. I. A review. , 1993, Optometry and vision science : official publication of the American Academy of Optometry.

[35]  Francis Heed Adler,et al.  Adler's Physiology of the eye;: Clinical application , 1976 .

[36]  N. Ishimaru,et al.  Analysis of in vivo role of alpha-fodrin autoantigen in primary Sjogren's syndrome. , 2005, The American journal of pathology.